Efficacy and safety of the intra-operative high-dose induction with ATG-fresenius in older kidney graft recipients

Transplantationsmedizin: Organ der Deutschen Transplantationsgesellschaft

Volumn 23, Issue 3, 2011, Pages 215-222

  Kaden, Jürgen ^a   May, Gottfried ^a   Völp, Andreas ^b   Wesslau, Claus ^a  

^a VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^b Psy Consult Scientific Services   (Germany)

Author keywords

ATG fresenius; Cyclosporine; Immunosuppression; Induction; Intra operative high dose induction; Kidney transplantation; Older recipients

Indexed keywords

EID: 84871906348     PISSN: 09469648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fabrizii V, Kovarik J, Bodingbauer M, Kramar R, Hörl WH, Winkelmayer WC (2005) Long-term patient and graft survival in the Eurotransplant Senior Program: a single-center experience. Transplantation 80: 582-89
2. Voiculescu A, Schlieper G, Hetzel GR et al. (2002) Kidney transplantation in the elderly: age-matching as compared to HLA-matching: a single center experience.Transplantation 73: 1356-1359
3. Beckurts UTE, Stippel D, Pollok M, Arns W Weber M, Hölscher AH (2001) Single-center experience with the "old-for-old" program for renal transplantation. Transplant Proc 33: 3779-3780
4. Krüger B, Zülke C, Fischereder M et al. (2002) Early experience with the ET Senior Program "old for old"; better to be number one? Transplant Int 15: 541-545
5. Bentas W, Jones J, Karaoguz A et al. (2008) Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme. Nephrol Dial Transplant 23: 2043-2051
6. Fritsche L, Hörstrup J, Budde K et al. (2003) Oldfor-old kidney allocation allow successful expansion of the donor and recipients pool. Am J Transplant 3: 1434-1439
7. Giessing M, Budde K, Fritsche L et al. (2003) "Oldfor-old" cadaveric renal transplantation: surgical findings, perioperative complications and outcome. Europ Urol 44: 701-708
8. Wolters H, Unser J, Schleicher C et al. (2010) European Senior Pragramm (ESP): Erfahrungen in Münster.Transplantationsmedizin 22: 133-137
9. Bodingbauer M, Pakrah B, Steininger R et al. (2006) The advantage of allocating kidneys from old cadaveric donors to old recipients: a singlecenter experience. Clin Transplant 20: 471-475
10. Arbogast HP, Hoffmann JN, Illner WD et al. (2009) Calcineurin inhibitor-free immunosuppressive strategy in elderly recipients of renal allografts from deceased donors: 1-year results from a prospective single center trial.Transplant Proc 41: 2529-2532
11. Guba M, Rentsch M, Wimmer CD et al. (2000) Calcineurin-inhibitor avoidance in elderly renal allograft recipients using ATG and basiliximab combined with mycophenolate mofetil. Transpl Int 21: 637-645
12. Laftavi MR, Patel S, Soliman MR et al. (2011) Lowdose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.Transplant Proc 43: 466-468
13. Patel SJ,Knight RJ,Suki WN et al. (2011) Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age. Clin Transplant; DOI: 10.1111/j.1399-0012.2010.01393.x.
14. Gavela Martinez E, Sancho Calabuig A, Escudero Quesada V et al. (2008) Induction treatment with low-dose thymoglobulin or basiliximab in renal transplant from older donors.Transplant Proc 40: 2900-2902
15. Kaden, J, May G, Schönemann C et al. (1992) Effect of ATG prophylaxis in sensitized and nonsensitized kidney graft recipients.Transplant Int 5 (Suppl. 1): S 75-S 78
16. Kaden J (1999) Optimal management of induction therapy with ATG in kidney allograft recipients. Int J Immunotherapy 15: 115-124
17. Kaden J, May G, Völp A, Wesslau C (2009) Improved long-term survival after intra-operative single high-dose ATG-Fresenius induction in renal transplantation: A single centre experience. Ann Transplant 14: 7-17
18. Groth J, Schönemann C, Kaden J, May G (1996) Dynamics of donor-reactive IgG, IgA and IgM antibodies against T and B lymphocytes early after clinical kidney transplantation using flow cytometry. Transplant Immunol 4: 215-19
19. Roodnat JI, Zietse R, Mulder PGH et al. (1999) The vanishing importance of age in renal transplantation. Transplantation 67: 576-80
20. Cohen B, Smits JM, Haase B, Persijn G, Vanrenterghem Y, Frei U (2005) Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 20: 34-41
21. Kauffman HM, McBride MA, Cors CS, Roza AM, Wynn JJ (2007) Early mortality rates in older kidney recipients with comorbid risk factors. Transplantation 83: 404-410
22. Danovich GM, Gill J, Bunnapradist S (2007) Immunosuppression of the elderly kidney transplant recipients.Transplantation 84: 285-291
23. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B (2001) Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int 59: 1539-1543
24. Huang E, Segev DL, Rabb H (2009) Kidney transplantation in the elderly. Semin Nephrol 29: 621-635
25. Falck P, Asberg A, Byberg KT et al. (2008) Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients. Transplantation 86:1379-1383